These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23694952)

  • 1. Inducible costimulator (ICOS) up-regulation on activated T cells in chronic graft-versus-host disease after dog leukocyte antigen-nonidentical hematopoietic cell transplantation: a potential therapeutic target.
    Sato M; Storb R; Loretz C; Stone D; Mielcarek M; Sale GE; Rezvani AR; Graves SS
    Transplantation; 2013 Jul; 96(1):34-41. PubMed ID: 23694952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).
    Taylor PA; Panoskaltsis-Mortari A; Freeman GJ; Sharpe AH; Noelle RJ; Rudensky AY; Mak TW; Serody JS; Blazar BR
    Blood; 2005 Apr; 105(8):3372-80. PubMed ID: 15618467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-ICOS mAb Targets Pathogenic IL-17A-expressing Cells in Canine Model of Chronic GVHD.
    Parker MH; Stone D; Abrams K; Johnson M; Granot N; Storb R
    Transplantation; 2021 May; 105(5):1008-1016. PubMed ID: 33065723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Inducible Costimulator Monoclonal Antibody Treatment of Canine Chronic Graft-versus-Host Disease.
    Graves SS; Parker MH; Stone D; Sale GE; Pillai SPS; Johnson MM; Storb R
    Biol Blood Marrow Transplant; 2018 Jan; 24(1):50-54. PubMed ID: 28958896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonistic and agonistic anti-canine CD28 monoclonal antibodies: tools for allogeneic transplantation.
    Graves SS; Stone DM; Loretz C; Peterson LJ; Lesnikova M; Hwang B; Georges GE; Nash R; Storb R
    Transplantation; 2011 Apr; 91(8):833-40. PubMed ID: 21343872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of CD28, CTLA4, and inducible costimulator in acute graft-versus-host disease in mice.
    Li J; Semple K; Suh WK; Liu C; Chen F; Blazar BR; Yu XZ
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):962-9. PubMed ID: 21447398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of inducible costimulator on alloreactive T cells reduces graft versus host disease and induces Th2 deviation.
    Hubbard VM; Eng JM; Ramirez-Montagut T; Tjoe KH; Muriglan SJ; Kochman AA; Terwey TH; Willis LM; Schiro R; Heller G; Murphy GF; Liu C; Alpdogan O; van den Brink MR
    Blood; 2005 Nov; 106(9):3285-92. PubMed ID: 15956289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposing effects of ICOS on graft-versus-host disease mediated by CD4 and CD8 T cells.
    Yu XZ; Liang Y; Nurieva RI; Guo F; Anasetti C; Dong C
    J Immunol; 2006 Jun; 176(12):7394-401. PubMed ID: 16751384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of B7RP-1/ICOS co-stimulation to lethal acute GVHD.
    Fujimura J; Takeda K; Kaduka Y; Saito M; Akiba H; Yagita H; Yamashiro Y; Shimizu T; Okumura K
    Pediatr Transplant; 2010 Jun; 14(4):540-8. PubMed ID: 20136724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple combination therapies involving blockade of ICOS/B7RP-1 costimulation facilitate long-term islet allograft survival.
    Nanji SA; Hancock WW; Anderson CC; Adams AB; Luo B; Schur CD; Pawlick RL; Wang L; Coyle AJ; Larsen CP; Shapiro AM
    Am J Transplant; 2004 Apr; 4(4):526-36. PubMed ID: 15023144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
    Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
    Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JTA-009, a fully human antibody against human AILIM/ICOS, ameliorates graft-vs-host reaction in SCID mice grafted with human PBMCs.
    Tajima N; Tezuka K; Tanimoto A; Miyai A; Tanimoto M; Maruhashi J; Watanabe Y
    Exp Hematol; 2008 Nov; 36(11):1514-23. PubMed ID: 18715691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of stem cell transcriptional programs normally expressed in embryonic and neural stem cells in alloreactive CD8+ T cells mediating graft-versus-host disease.
    Kato K; Cui S; Kuick R; Mineishi S; Hexner E; Ferrara JL; Emerson SG; Zhang Y
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):751-71. PubMed ID: 20116439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Donor-Reactive CD8+ T Cell Responses by Selective CD28 Blockade Is Independent of Reduced ICOS Expression.
    Liu D; Suchard SJ; Nadler SG; Ford ML
    PLoS One; 2015; 10(6):e0130490. PubMed ID: 26098894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients.
    Blazar BR; Sharpe AH; Chen AI; Panoskaltsis-Mortari A; Lees C; Akiba H; Yagita H; Killeen N; Taylor PA
    Blood; 2003 May; 101(9):3741-8. PubMed ID: 12521997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged survival in rat liver transplantation with mouse monoclonal antibody against an inducible costimulator (ICOS).
    Guo L; Li XK; Funeshima N; Fujino M; Nagata Y; Kimura H; Amemiya H; Enosawa S; Tsuji T; Harihara Y; Makuuchi M; Suzuki S
    Transplantation; 2002 Apr; 73(7):1027-32. PubMed ID: 11965027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity.
    Harada H; Salama AD; Sho M; Izawa A; Sandner SE; Ito T; Akiba H; Yagita H; Sharpe AH; Freeman GJ; Sayegh MH
    J Clin Invest; 2003 Jul; 112(2):234-43. PubMed ID: 12865411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. During acute graft versus host disease CD28 deletion in donor CD8
    Uri A; Lühder F; Kerkau T; Beyersdorf N
    Eur J Immunol; 2018 Dec; 48(12):2055-2067. PubMed ID: 30320878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells.
    McAdam AJ; Chang TT; Lumelsky AE; Greenfield EA; Boussiotis VA; Duke-Cohan JS; Chernova T; Malenkovich N; Jabs C; Kuchroo VK; Ling V; Collins M; Sharpe AH; Freeman GJ
    J Immunol; 2000 Nov; 165(9):5035-40. PubMed ID: 11046032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans.
    Flynn R; Du J; Veenstra RG; Reichenbach DK; Panoskaltsis-Mortari A; Taylor PA; Freeman GJ; Serody JS; Murphy WJ; Munn DH; Sarantopoulos S; Luznik L; Maillard I; Koreth J; Cutler C; Soiffer RJ; Antin JH; Ritz J; Dubovsky JA; Byrd JC; MacDonald KP; Hill GR; Blazar BR
    Blood; 2014 Jun; 123(25):3988-98. PubMed ID: 24820310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.